Report Code : CVMI29123752 | Published Date : March 26, 2025
nan
Reasons To Buy
nan
Scope
nan
Key Players
- Alopecia Treatment Market – Johnson & Johnson
- Merck & Co. Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Cipla Ltd.
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy’s Laboratories
- Cellmid Limited
- Follicum AB
- Concert Pharmaceuticals Inc.
Europe Alopecia Treatment Market Report
-
1. Europe Alopecia Treatment Market Research Report
- 1.1 Study Objectives
- 1.2 Europe Alopecia Treatment Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Europe Alopecia Treatment Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Treatment Type
- 2.1.2 By End-user
- 2.1.3 By Application
- 2.1.4 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Treatment Type, By End-user, By Application, By Country
- 3.3. Opportunities – By Treatment Type, By End-user, By Application, By Country
- 3.4. Trends – By Treatment Type, By End-user, By Application, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Europe Alopecia Treatment Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Topical Treatment
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Oral Treatment
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Injectable Treatment
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.4 Hair Transplantation
- 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Hospitals
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Clinics
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Homecare Settings
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Male Alopecia
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Female Alopecia
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 Europe
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.2 Europe Alopecia Treatment Market - Opportunity Analysis Index,
By Treatment Type,
By End-user,
By Application,
and Region, 2024 - 2031
- 9.1.1 Topical Treatment
- 9.1.2 Oral Treatment
- 9.1.3 Injectable Treatment
- 9.1.4 Hair Transplantation
- 9.2.1 Hospitals
- 9.2.2 Clinics
- 9.2.3 Homecare Settings
- 9.3.1 Male Alopecia
- 9.3.2 Female Alopecia
- 9.4.1 Germany
- 9.4.2 United Kingdom
- 9.4.3 France
- 9.4.4 Spain
- 9.4.5 Italy
- 9.4.6 Russia
- 9.4.7 Netherlands
- 9.4.8 Poland
- 9.4.9 Rest of Europe
- 9.7.1 Company 1 (Germany)
- 9.7.2 Company 2 (United Kingdom)
- 9.7.3 Company 3 (United Kingdom)
- 10.2.1 Alopecia Treatment Market – Johnson & Johnson
- 10.2.2 Merck & Co. Inc.
- 10.2.3 Pfizer Inc.
- 10.2.4 GlaxoSmithKline plc
- 10.2.5 Cipla Ltd.
- 10.2.6 Sun Pharmaceutical Industries Ltd.
- 10.2.7 Dr. Reddy’s Laboratories
- 10.2.8 Cellmid Limited
- 10.2.9 Follicum AB
- 10.2.10 Concert Pharmaceuticals Inc.
-
9.1 By Treatment Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.6 Regional Trends Analysis
9.7 Europe Europe Alopecia Treatment Market Research Report - Company Profiles
-
10.1 Strategic Dashboard of Top Market Players
10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
12. Principal Presumptions and Acronyms